Inventor · name-matched record
BABU YARLAGADDA S
7 granted patents·2 pending applications·0 citations·filing 2020–2025
77Inventor score
Files withBIOCRYST PHARM INC9
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
9 records- 0194US2026092045A1Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2025·Application pending·0 cites
- 0293US12590069B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2025·Granted Mar 31, 2026·0 cites·30 claims
- 0393US12590068B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2025·Granted Mar 31, 2026·0 cites·30 claims
- 0493US12552750B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2025·Granted Feb 17, 2026·0 cites·28 claims
- 0593US12545646B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2025·Granted Feb 10, 2026·0 cites·28 claims
- 0693US12545645B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2025·Granted Feb 10, 2026·0 cites·28 claims
- 0793US12545647B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2025·Granted Feb 10, 2026·0 cites·28 claims
- 0863US2026028389A1Fusion protein inhibitors of klk5BIOCRYST PHARM INC·Filed 2023·Application pending·0 cites
- 0949US12558341B2Oral complement factor D inhibitorsBIOCRYST PHARM INC·Filed 2020·Granted Feb 24, 2026·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when BABU YARLAGADDA S files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →